Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.
2.

Role of colesevelam in combination lipid-lowering therapy.

Jones MR, Nwose OM.

Am J Cardiovasc Drugs. 2013 Oct;13(5):315-23. doi: 10.1007/s40256-013-0037-0. Review.

3.

Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.

Dayer-Berenson L, Finckenor M.

Postgrad Med. 2014 May;126(3):126-34. doi: 10.3810/pgm.2014.05.2762. Review.

PMID:
24918798
5.

Safety and efficacy of colesevelam HCl in the treatment of elderly patients.

Gavin JR 3rd, Jones MR, Ford DM, Truitt KE.

Drugs Aging. 2014 Jun;31(6):461-70. doi: 10.1007/s40266-014-0174-4.

6.
7.

Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.

Jones MR, Mudaliar S, Hernandez-Triana E, Unnikrishnan AG, Lai YL, Abby SL, Misir S, Jin X, Nagendran S.

Curr Med Res Opin. 2009 Sep;25(9):2239-49. doi: 10.1185/03007990903126791.

PMID:
19622007
8.

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

Bays HE, Goldberg RB, Truitt KE, Jones MR.

Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.

PMID:
18852398
10.
11.

The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.

Brunetti L, Hermes-Desantis ER.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1196-206. doi: 10.1345/aph.1M728. Epub 2010 Jun 15. Review.

PMID:
20551301
12.

The role of colesevelam HCl in type 2 diabetes mellitus therapy.

Handelsman Y.

Postgrad Med. 2009 May;121(3 Suppl 1):19-24. doi: 10.3810/pgm.2009.05.suppl53.289. Review.

PMID:
19494474
13.
14.

Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.

Goldberg RB, Rosenson RS, Hernandez-Triana E, Misir S, Jones MR.

J Clin Lipidol. 2012 Jul-Aug;6(4):318-24. doi: 10.1016/j.jacl.2012.05.005. Epub 2012 May 29.

PMID:
22836068
15.
16.

The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.

Davidson M.

Clin Ther. 2013 Aug;35(8):1247-52. doi: 10.1016/j.clinthera.2013.06.014. Epub 2013 Jul 31. Review.

PMID:
23916045
17.

The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.

Goldfine AB, Fonseca VA.

Postgrad Med. 2009 May;121(3 Suppl 1):13-8. doi: 10.3810/pgm.2009.05.suppl53.288. Review.

PMID:
19494473
18.

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.

Goldberg RB, Fonseca VA, Truitt KE, Jones MR.

Arch Intern Med. 2008 Jul 28;168(14):1531-40. doi: 10.1001/archinte.168.14.1531.

PMID:
18663165
19.

The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.

Wright WL.

Adv Nurse Pract. 2009 Nov;17(11):suppl 1-16. No abstract available.

PMID:
20014684
20.

Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.

Rosenstock J, Fonseca VA, Garvey WT, Goldberg RB, Handelsman Y, Abby SL, Lai YL, Jin X, Misir S, Nagendran S, Jones MR.

Endocr Pract. 2010 Jul-Aug;16(4):629-40. doi: 10.4158/EP10130.OR.

PMID:
20634175

Supplemental Content

Support Center